Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
INO Inovio Pharmaceuticals
1.840
+0.010+0.55%
Post Mkt Price
1.810
-0.030-1.63%
Symbol
INO
Company Name
Inovio Pharmaceuticals
Listing Date
12/08/1998
Establishment Date
1983
CEO
Dr. Jacqueline E. Shea
Market
NASDAQ
Employees
317
Securities Type
DR
Fiscal Year Ends
12-31
Address
660 West Germantown Pike,Suite 110
City
Plymouth Meeting
Province
Pennsylvania
Country
United States of America
Zip code
19462-1111
Phone
1-267-440-4200
Profile
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Company Overview
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
CEO: Dr. Jacqueline E. Shea
Market: NASDAQ
Listing Date: 12/08/1998
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist